Freedom Investment Management, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2019$248,000
-47.7%
2,154
-48.8%
0.02%
-26.7%
Q3 2018$474,000
+9.2%
4,209
-13.0%
0.03%
+15.4%
Q2 2018$434,000
+9.9%
4,840
-28.8%
0.03%
+30.0%
Q4 2017$395,000
+2.9%
6,801
-20.5%
0.02%
-4.8%
Q3 2017$384,000
+25.9%
8,554
+10.9%
0.02%
+23.5%
Q2 2017$305,0007,7130.02%
Other shareholders
HAEMONETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders